257 related articles for article (PubMed ID: 29419761)
1. A-Kinase Anchoring Protein-Lbc: A Molecular Scaffold Involved in Cardiac Protection.
Diviani D; Osman H; Reggi E
J Cardiovasc Dev Dis; 2018 Feb; 5(1):. PubMed ID: 29419761
[TBL] [Abstract][Full Text] [Related]
2. AKAP-Lbc: a molecular scaffold for the integration of cyclic AMP and Rho transduction pathways.
Diviani D; Baisamy L; Appert-Collin A
Eur J Cell Biol; 2006 Jul; 85(7):603-10. PubMed ID: 16460837
[TBL] [Abstract][Full Text] [Related]
3. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
Burmeister BT; Taglieri DM; Wang L; Carnegie GK
J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
[TBL] [Abstract][Full Text] [Related]
4. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
Cavin S; Maric D; Diviani D
Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
[TBL] [Abstract][Full Text] [Related]
5. The Role of Cyclic AMP Signaling in Cardiac Fibrosis.
Delaunay M; Osman H; Kaiser S; Diviani D
Cells; 2019 Dec; 9(1):. PubMed ID: 31888098
[TBL] [Abstract][Full Text] [Related]
6. The role of A-kinase anchoring proteins in cardiac oxidative stress.
Diviani D; Osman H; Delaunay M; Kaiser S
Biochem Soc Trans; 2019 Oct; 47(5):1341-1353. PubMed ID: 31671182
[TBL] [Abstract][Full Text] [Related]
7. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex.
Diviani D; Abuin L; Cotecchia S; Pansier L
EMBO J; 2004 Jul; 23(14):2811-20. PubMed ID: 15229649
[TBL] [Abstract][Full Text] [Related]
8. Disruptors of AKAP-Dependent Protein-Protein Interactions.
Walker-Gray R; Pallien T; Miller DC; Oder A; Neuenschwander M; von Kries JP; Diecke S; Klussmann E
Methods Mol Biol; 2022; 2483():117-139. PubMed ID: 35286673
[TBL] [Abstract][Full Text] [Related]
9. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiology.
Diviani D; Reggi E; Arambasic M; Caso S; Maric D
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1926-36. PubMed ID: 26643253
[TBL] [Abstract][Full Text] [Related]
11. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
12. A-Kinase Anchoring Protein 2 Promotes Protection against Myocardial Infarction.
Maric D; Paterek A; Delaunay M; López IP; Arambasic M; Diviani D
Cells; 2021 Oct; 10(11):. PubMed ID: 34831084
[TBL] [Abstract][Full Text] [Related]
13. AKAP-Lbc mediates protection against doxorubicin-induced cardiomyocyte toxicity.
Caso S; Maric D; Arambasic M; Cotecchia S; Diviani D
Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2336-2346. PubMed ID: 28923249
[TBL] [Abstract][Full Text] [Related]
14. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
Taglieri DM; Johnson KR; Burmeister BT; Monasky MM; Spindler MJ; DeSantiago J; Banach K; Conklin BR; Carnegie GK
J Mol Cell Cardiol; 2014 Jan; 66():27-40. PubMed ID: 24161911
[TBL] [Abstract][Full Text] [Related]
15. Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity.
Burmeister BT; Wang L; Gold MG; Skidgel RA; O'Bryan JP; Carnegie GK
J Biol Chem; 2015 May; 290(19):12058-67. PubMed ID: 25802336
[TBL] [Abstract][Full Text] [Related]
16. Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy.
Rababa'h A; Singh S; Suryavanshi SV; Altarabsheh SE; Deo SV; McConnell BK
Int J Mol Sci; 2014 Dec; 16(1):218-29. PubMed ID: 25547489
[TBL] [Abstract][Full Text] [Related]
17. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms/Mutations in A-Kinase Anchoring Proteins (AKAPs): Role in the Cardiovascular System.
Suryavanshi SV; Jadhav SM; McConnell BK
J Cardiovasc Dev Dis; 2018 Jan; 5(1):. PubMed ID: 29370121
[TBL] [Abstract][Full Text] [Related]
19. A-kinase anchoring proteins: molecular regulators of the cardiac stress response.
Diviani D; Maric D; Pérez López I; Cavin S; Del Vescovo CD
Biochim Biophys Acta; 2013 Apr; 1833(4):901-8. PubMed ID: 22889610
[TBL] [Abstract][Full Text] [Related]
20. Leucine zipper-mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc.
Baisamy L; Jurisch N; Diviani D
J Biol Chem; 2005 Apr; 280(15):15405-12. PubMed ID: 15691829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
